Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1687 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

China Baicaotang Q4 Revenue Up

China Baicaotang posted a net income of $4.03m, or $0.13 per diluted share, compared to $3.07m, or $0.10 per diluted share, for the same period in 2008. Operating

QRxPharma Begins MoxDuo CR Phase 1 Trial

MoxDuo CR contains a fixed 3:2 morphine:oxycodone combination and is intended to be dosed twice daily in patients experiencing chronic pain. In accordance with the recently approved IND